Literature DB >> 14570304

Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption.

Kevin C Johnson1.   

Abstract

A previously described model for simulating drug dissolution, absorption, and pharmacokinetics has been expanded beyond the original application of simulating immediate-release dosage forms to include simulation of drug precipitation, water absorption from the gastrointestinal tract, changing gastrointestinal permeability, disintegration, and controlled-release and dissolution from a GITS-type dosage form. A mathematical description of the model is presented as well as a retrospective analysis of nifedipine to demonstrate the utility of the model. The fourth-order Runge-Kutta numerical method was used to solve the series of coupled differential equations used to simulate the process of dissolution, absorption, and drug disposition. The model was able to simulate the clinically demonstrated effect for drug particle size on nifedipine plasma concentrations for an immediate-release dosage form. Further simulations indicated that drug particle size was less important for a GITS-type dosage form at a release rate of 1.7 mg/hr compared to rate of 17 mg/hr. Hypothetical calculations simulated the potential effect of drug precipitation, water absorption, and changing permeability on drug plasma concentrations. The expanded model increases the utility of a previously described model in providing guidance in drug development and selection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570304     DOI: 10.1081/ddc-120024179

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  10 in total

1.  Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.

Authors:  Filippos Kesisoglou; Binfeng Xia; Nancy G B Agrawal
Journal:  AAPS J       Date:  2015-08-20       Impact factor: 4.009

2.  A simple absorption model for dose-escalating studies.

Authors:  Anders Källén
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-07       Impact factor: 2.745

3.  A modified approach to predict dissolution and absorption of polydisperse powders.

Authors:  John C Butcher; Sanjay Garg; Dawoomi Kim; Puneet Sharma
Journal:  Pharm Res       Date:  2008-06-04       Impact factor: 4.200

4.  Application of Absorption Modeling in Rational Design of Drug Product Under Quality-by-Design Paradigm.

Authors:  Filippos Kesisoglou; Amitava Mitra
Journal:  AAPS J       Date:  2015-05-22       Impact factor: 4.009

5.  Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.

Authors:  Mary S Kleppe; Kelly M Forney-Stevens; Roy J Haskell; Robin H Bogner
Journal:  AAPS J       Date:  2015-04-08       Impact factor: 4.009

Review 6.  Population-based mechanistic prediction of oral drug absorption.

Authors:  Masoud Jamei; David Turner; Jiansong Yang; Sibylle Neuhoff; Sebastian Polak; Amin Rostami-Hodjegan; Geoffrey Tucker
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

7.  A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.

Authors:  Daniel Moj; Hannah Britz; Jürgen Burhenne; Clinton F Stewart; Gerlinde Egerer; Walter E Haefeli; Thorsten Lehr
Journal:  Cancer Chemother Pharmacol       Date:  2017-10-07       Impact factor: 3.333

8.  Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin.

Authors:  Andrés Olivares-Morales; Avijit Ghosh; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-09-08       Impact factor: 4.009

9.  Mechanistic modeling of gastrointestinal motility with integrated dissolution for simulating drug absorption.

Authors:  Kevin C Johnson
Journal:  ADMET DMPK       Date:  2020-06-09

10.  Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Authors:  Stefan Willmann; Corina Becker; Rolf Burghaus; Katrin Coboeken; Andrea Edginton; Jörg Lippert; Hans-Ulrich Siegmund; Kirstin Thelen; Wolfgang Mück
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.